Third Moderna Shot Moves Forward

by Chris Black

You know that saying, the third time is the charm. The EU is rolling out the 3rd dose of Spikewax, even if there are numerous reports about side effects.

We are primarily funded by readers. Please subscribe and donate to support us!


But who cares, right? 

Zacks Equity Research:

Moderna, Inc. announced that the European Medicines Agency (EMA) has authorized the third dose of its mRNA-based COVID-19 vaccine, Spikevax (mRNA-1273), for use in certain immunocompromised individuals aged 12 years or older. The additional dose needs to be administered after at least 28 days from the completion of the initial two-dose regimen.



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.